Roger Perlmutter lights up the biological dark, building a new pharma force in Eikon and its superpowered microscopes

The company’s audacious goal is nothing short of being able to look at the real-time mechanics of the cell at the level of individual proteins, using Nobel Prize-winning microscope technology at an industrial scale to identify and treat new, challenging drug targets.

Read in the News